Is an SGLT2 inhibitor right for your patient with type 2 diabetes?
Metformin isn't quite doing the job or is contraindicated? Here's a look at the patients who may benefit from these agents and the monitoring required.
Department of Pharmacy Practice, Auburn University, Harrison School of Pharmacy, AL, USA. Email: kmh0003@auburn.edu.
Katelin M
KM
Lisenby
Department of Pharmacy Practice, Auburn University, Harrison School of Pharmacy, AL, USA.
Allison
A
Meyer
Department of Pharmacy Practice, Auburn University, Harrison School of Pharmacy, AL, USA.
Nicole A
NA
Slater
D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000592:standards* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D051297:Sodium-Glucose Transporter 2 / Q000819:agonists*; D014481:United States
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2; D008687:Metformin